Biotech Target N V - Sep 28, 2021 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
10%+ Owner
Signature
/s/ Daniel Koller
Stock symbol
MGNX
Transactions as of
Sep 28, 2021
Transactions value $
$4,111,420
Form type
4
Date filed
9/30/2021, 03:09 PM
Previous filing
Sep 24, 2021
Next filing
Oct 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Purchase $2.06M +100K +1.45% $20.64 6.98M Sep 28, 2021 Direct
transaction MGNX Common Stock Purchase $2.05M +100K +1.43% $20.47 7.08M Sep 29, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Macrogenics, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.